Table 5.
Drug Name | Therapy Type | Condition | Status |
---|---|---|---|
AZD0530 | Small molecule therapy | Alzheimer’s Disease, Parkinson’s Disease | AD (Discontinued), PD (Phase 1) |
CT1812 (Elayta) | Small molecule therapy | Alzheimer’s disease | (Phase 2) |
Drug Name | Therapy Type | Condition | Status |
---|---|---|---|
AZD0530 | Small molecule therapy | Alzheimer’s Disease, Parkinson’s Disease | AD (Discontinued), PD (Phase 1) |
CT1812 (Elayta) | Small molecule therapy | Alzheimer’s disease | (Phase 2) |